Lapatinib Active Not Recruiting Phase 2 Trials for Geriatric Health Services / HER2/Neu Positive / Neoplasms, Breast Treatment

Active Not RecruitingTreatment2 IdentifierTitleDrugs
NCT00444535Lapatinib and Bevacizumab for Metastatic Breast Cancer
NCT02213042Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer
NCT01273610Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer